Tricog strengthens ties with Sanofi and OMRON Healthcare to advance Indian cardiac innovation, expand global reach and improve access to early diagnosis.
Moderna stock slumps on cancer shot data, while Pfizer and Valneva advance Lyme vaccine prospects and malaria vaccine prices fall.
Tamil Nadu's dengue vaccine pilot will assess Qdenga's local performance, safety and delivery to inform future vaccination decisions.
Leucine Rich Bio's vaginal microbiome test brings personalised women's health insights into focus, raising questions about clinical utility and diagnostic evidence.
The Zydus drug recall affects 70,776 injectable vials in the US after the medicine failed impurity and degradation specifications.
Roche Q3 CEETRIS growth highlights India’s strategic importance as the company’s International region expands and demand for specialty medicines rises.
Abbott plans a nutrition spin-off by 2027 while cutting its 2026 sales growth forecast, reshaping its healthcare portfolio and growth strategy.
The FDA clears a lower-cost generic HRT patch from Zydus and approves AstraZeneca’s Ultomiris for adults with IgA nephropathy, expanding menopause care and kidney disease treatment options.
Sanofi's Qfitlia approval puts haemophilia prophylaxis in India in focus as research highlights gaps in preventive treatment.
Toripalimab's expanded use in India brings real-world evidence into focus, with a multicentre study examining treatment outcomes across PD-L1 subgroups.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
